ZFP36 RNA-binding proteins restrain T cell activation and anti-viral immunity
Year: 2018
Type: article
Abstract: Dynamic post-transcriptional control of RNA expression by RNA-binding proteins (RBPs) is critical during immune response. ZFP36 RBPs are prominent inflammatory regulators linked to autoimmunity and cancer, but functions in adaptive immunity are less clear. We used HITS-CLIP to define ZFP36 targets in mouse T cells, revealing unanticipated actions in regulating T-cell activation, proliferation, and effector functions. Transcriptome and ribosome profiling showed that ZFP36 represses mRNA target abundance and translation, notably through novel AU-rich sites in coding sequence. Functional studies revealed that ZFP36 regulates early T-cell activation kinetics cell autonomously, by attenuating activation marker expression, limiting T cell expansion, and promoting apoptosis. Strikingly, loss of ZFP36 in vivo accelerated T cell responses to acute viral infection and enhanced anti-viral immunity. These findings uncover a critical role for ZFP36 RBPs in restraining T cell expansion and effector functions, and suggest ZFP36 inhibition as a strategy to enhance immune-based therapies.
Source: eLife
DOI: 10.7554/elife.33057
Language: English
Topic: RNA Research and Splicing
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,500
Awards: Mapping the mechanisms of protein synthesis-dependent synaptic plasticity, Neurology and the molecular role of N-RBPs in the brain, Neurology and the molecular role of N-RBPs in the brain, Combining New Molecular and Informatic Strategies to Find Hidden Ways to Treat Brain Disease, G9000252022, Cancer Center Support Grant
OpenAlex ID: W2950891099
